Likelihood of survival of coronavirus disease 2019.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

118 citing papers in PubMed, 5 syntheses or guidelines pooled it.

1. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.British journal of clinical pharmacology · 2022 · on this map
   Pooled it
2. Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis.Journal of medical virology · 2020
   Pooled it
3. The impact of SARS-CoV-2 on the mental health of healthcare workers in a hospital setting-A Systematic Review.Journal of occupational health · 2020
   Pooled it
4. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis.Travel medicine and infectious disease
   Pooled it
5. The association between COVID-19 and type 1 diabetes mellitus: A systematic review.Diabetes & metabolic syndrome
   Pooled it
6. Initial functional disability as a 1-year prognostic factor in geriatric patients hospitalized with SARS-CoV-2 infection.PloS one · 2023
   Trial
7. Biguanides are associated with decreased early mortality and risk of acute kidney injury in hospitalised patients with COVID-19: a nationwide retrospective cohort study in Japan.Clinical and experimental nephrology · 2026
   Article
8. Progress in research on osteoporosis secondary to SARS-CoV-2 infection.Animal models and experimental medicine · 2025
   Review
9. Rate of advance care planning practice during the COVID-19 outbreak in Japan: a cross-sectional survey study.Aging clinical and experimental research · 2025
   Article
10. Infectious biomarkers upon admission predict in-hospital mortality in COVID-19 patients with and without chronic heart failure.Frontiers in cellular and infection microbiology · 2025
    Article
11. Echocardiographic Assessment in Patients Recovered from Acute COVID-19 Illness.Journal of cardiovascular development and disease · 2023
    Article
12. Physician's hesitancy in treating COVID-19 patients and its associated occupational risk factors in Indonesia: an online cross-sectional survey.Journal of public health in Africa · 2023
    Article
13. A deep learning predictive model for public health concerns and hesitancy toward the COVID-19 vaccines.Scientific reports · 2023
    Article
14. Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland.Open heart · 2023
    Article
15. Assessment of GO-Based Protein Interaction Affinities in the Large-Scale Human-Coronavirus Family Interactome.Vaccines · 2023
    Article
16. Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
17. Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection.NPJ vaccines · 2022
    Article
18. Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities.World journal of clinical cases · 2022
    Review
19. Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections.Clinical and translational medicine · 2022
    Review
20. NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study.Internal and emergency medicine · 2022
    Article

58 more citing papers are in PubMed but not listed here.

Corrections and comments

• Commented on by
  Ethics in the age of COVID-19.2020
• Comment on
  Estimates of the severity of coronavirus disease 2019: a model-based analysis.2020
• Erratum issued
  Correction to Lancet Infect Dis 2020; published online March 30. https://doi.org/10.1016/S1473-3099(20)30257-7.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as